| D | F | E |  |
 | |
 | |
  |
|
| index Me | previous | next | |
Meatherall R.[1]; Sharma P.[2]
| Authors |
CASE REPORT: Foxy, a Designer Tryptamine Hallucinogen | Title |
J Anal Toxicol 2003, 27/5, 313-317
| Source |
| Hallucinogens, Designer drugs
| Index terms |
| Foxy is slang for 5-methoxy-N,N-diisopropyltryptamine. It has hallucinogenic properties, similar to other tryptamine compounds, and is mildly euphoric. This case report describes a 21-year-old Caucasian man who ingested a pill called Foxy containing an unknown amount of drug. He was observed in hospital for 2 h, during which time he had mild hallucinations and could not move his limbs. A urine sample was collected approximately 4 h after drug ingestion. The patient was then discharged with no follow up assessment. The 5-methoxy-N,N-diisopropyltryptamine was identified in the urine by gas chromatographymass spectrometry. Standards prepared from the pure material were used in the identification. Quantitative analysis using the same analytical technique resulted in a urinary concentration of 1.7 µg/mL. Through oxidative deamination, the metabolite, 5-methoxy-indole acetic acid, was formed. It was identified in the urine, and the concentration was determined to be 1.3 µg/mL using gas chromatographymass spectrometry. Two other compounds were discovered in the urine sample as a result of a routine drug screen. From their mass spectra, they were tentatively identified as 5-methoxy-N-isopropyltryptamine and -methoxy-N,N-diisopropyltryptamine-N'-oxide.
| Abstract |
| Article
| Type |
| Disclaimer: The producers of these references take care to avoid errors but cannot be hold responsible for inaccuracies. Also, knowledge is constantly changing and the reader is advised to search carefully for the most recent and relevant studies.
| |
page generated by mib |